News and Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Center for Genetic Medicine. The links below take you to articles where you can learn more about our members' latest achievements, awards and honors.
Scientists have identified new genes linked to heart failure, according to a study published in Nature Communications.
Northwestern Medicine scientists have identified pathogenic variants in two genes linked to microcephaly and other neurodevelopmental disorders in children, according to a recent study published in Nature Communications.
Genetic testing in epilepsy patients can inform treatment and lead to better outcomes in many cases, according to a study published in JAMA Neurology.
- Center for Genetic Medicine Announces New Director for Transgenic and Targeted Mutagenesis Laboratory10.12.2022
Styliani (Stella) Markoulaki, PhD, has been named the new director of the Transgenic and Targeted Mutagenesis Laboratory.
Bigger test panels are better for genetic testing in cardiomyopathy and heart arrhythmias, according to a recent Northwestern Medicine study.
Northwestern Medicine investigators have discovered novel mechanisms underlying transcription elongation, the process of synthesizing RNA from DNA.
An immune system kinase promotes tumor inflammation and progression, according to a study published in Nature Communications.
An epigenetic inhibitor increased immune system activity in patients with ovarian cancer.
An enzymatic modifier of messenger RNA has different functions depending on its location, according to a recent study.
A deep learning model has discovered genetic variations in cancer that are undetectable in traditional genome sequencing.
Recent studies have pointed to an expanded role for non-coding RNA, according to a Northwestern Medicine review.
Investigators have discovered a new method to determine whether individual genetic variants in the epilepsy-associated gene SZT2 cause the neurodevelopmental disorder, according to a Northwestern Medicine study.
A newly discovered inhibitor of a common cancer-causing protein operates selectively, reducing expression of genes that fuel rampant cell proliferation, and altering the epigenome, according to a recent study.
Northwestern Medicine investigators have discovered a potential therapeutic target for the most common type of pancreatic cancer, according to a study published in Developmental Cell.
A transcription factor associated with androgen receptor activity in prostate cancer has a newly discovered role in controlling lipid biosynthesis.
Northwestern Medicine scientists identified critical regulatory processes that govern differentiation in embryonic stem cells.
Isabella Salamone, an eighth-year student in the Driskill Graduate Program in Life Sciences, was lead author of a study published in the Journal of Clinical Investigation, which found that glucocorticoid steroids improved muscle performance through distinct, sex-specific molecular pathways.
Epigenetic markers of cognitive aging can predict outcomes on cognitive tests later in life, according to a recent Northwestern Medicine study.
A recent study published in Nature Genetics identified 10 new genetic regions associated with Brugada syndrome, a cardiac arrhythmia disorder.
Daniel Brat, MD, PhD, has been heavily involved in the process of moving molecular genetic biomarkers for glioma from the bench to the beside.
Glucocorticoid steroids improved muscle performance through distinct, sex-specific mechanisms, according to a Northwestern Medicine study.
Northwestern Medicine scientists discovered functional links between dozens of potassium channel gene variants and neonatal epilepsy.
A genetic analysis indicates eosinophilic colitis is distinct from other eosinophilic gastrointestinal diseases and inflammatory bowel disease, according to a recent study.
Idiopathic dilated cardiomyopathy (DCM) was found to have a familial etiology in 30 percent of individuals diagnosed with DCM, and the overall risk for a family member of developing DCM was nearly 20 percent by the age of 80.
Sequencing known cardiac arrythmia genes in more than 20,000 people without an indication for genetic testing identified pathogenic variants in nearly one percent of individuals.